NOS3 Glu298Asp polymorphism interacts with virgin olive oil phenols to determine the postprandial endothelial function in patients with the metabolic syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 10, 2011, Pages

  Jiménez Morales, Ana I ^a   Ruano, Juan ^a   Delgado Lista, Javier ^a   Fernandez, Juan M ^a   Camargo, Antonio ^a   López Segura, Fernando ^a   Villarraso, Javier Caballero ^a   Fuentes Jiménez, Francisco ^a   López Miranda, Jose ^a   Pérez Jiménez, Francisco ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRATE; NITRITE; OLIVE OIL; PHENOL DERIVATIVE;

ADULT; ARTICLE; BLOOD VESSEL PARAMETERS; DIETARY INTAKE; ENDOTHELIUM; FEMALE; GENE; GENE DIET INTERACTION; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NOS3 GENE; POSTOCCLUSIVE SKIN REACTIVE HYPEREMIA; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ADULT; AGED; ENDOTHELIUM, VASCULAR; FEMALE; GENOTYPE; HUMANS; HYPEREMIA; LASER-DOPPLER FLOWMETRY; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHENOLS; PLANT OILS; POLYMORPHISM, GENETIC; POSTPRANDIAL PERIOD; RISK FACTORS;

EID: 80053529055     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1056     Document Type: Article

References (42)

1. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S 2009 Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 32(Suppl 2):S314-S321
2. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, Kiowski W, Lü scher TF, Mancia G, Natali A, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Spieker LE, Taddei S, Webb DJ 2005 Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases.Astatement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 23:233-246 (Pubitemid 40279622)
3. Taddei S, Ghiadoni L, Virdis A, Versari D, Salvetti A 2003 Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategies. Curr Pharm Des 9:2385-2402 (Pubitemid 37236360)
4. Chidlow Jr JH, Sessa WC 2010 Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res 86:219-225
5. Velloso MW, Pereira SB, Gouveia L, Chermont S, Tardin OM, Gonçalves R, Camacho V, Contarato Lde F, Quintão M, Oliveira e Alves T, Pessoa LP, Brito Jú nior A, Ribeiro GS, Mesquita ET 2010 Endothelial nitric oxide synthase Glu298Asp gene polymorphism in a multi-ethnical population with heart failure and controls. Nitric Oxide 22:220-225
6. Hsieh MC, Hsiao JY, Tien KJ, Chang SJ, Lin PC, Hsu SC, Liang HT, Chen HC, Lin SR 2008 The association of endothelial nitric oxide synthase G894T polymorphism with C-reactive protein level and metabolic syndrome in a Chinese study group. Metabolism 57:1125-1129
7. Han Y, Xu W, Zhang W, Liu N, Ji Y 2010 T-786C polymorphism in the endothelial nitric oxide synthase gene is associated with increased risk of coronary artery disease in a Chinese population. Pharmacology 85:211-216
8. Isordia-Salas I, Leaños-Miranda A, Borrayo-Sánchez G 2010 The Glu298ASP polymorphism of the endothelial nitric oxide synthase gene is associated with premature ST elevation myocardial infarction in Mexican population. Clin Chim Acta 411:553-557
9. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T, Ochiai H, Kosuge M, Watanabe Y, Yoshii Y, Kihara M, Kimura K, Ishii M, Umemura S 1998 Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32:521-526 (Pubitemid 28429143)
10. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ 1999 A common variant of the endothelial nitric oxide synthase (Glu298->Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100:1515-1520 (Pubitemid 29461463)
11. Eifert S, Rasch A, Beiras-Fernandez A, Nollert G, Reichart B, Lohse P 2009 Gene polymorphisms in APOE, NOS3, and LIPC genes may be risk factors for cardiac adverse events after primary CABG. J Cardiothorac Surg 4:46
12. Wang CJ, Zhao JB, Xu JL, Xiang ZL, Liang CW, Li J 2009 [Metaanalysis on the association of G894T polymorphism in endothelial nitric oxide synthase gene and essential hypertension in Chinese population.]. Zhonghua Liu Xing Bing Xue Za Zhi 30:845-849
13. Piccoli JC, Gottlieb MG, Castro L, Bodanese LC, Manenti ER, Bogo MR, Peres A, Rocha MI, Cruz IB 2008 Association between 894G>T endothelial nitric oxide synthase gene polymorphisms and metabolic syndrome. Arq Bras Endocrinol Metabol 52:1367-1373
14. González-Sánchez JL, Martínez-Larrad MT, Sáez ME, Zabena C, Martínez-Calatrava MJ, Serrano-Ríos M 2007 Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome. Clin Chem 53:91-97 (Pubitemid 46047767)
15. Tso AW, Tan KC, Wat NM, Janus ED, Lam TH, S L Lam K 2006 Endothelial nitric oxide synthase G894T (Glu298Asp) polymorphism was predictive of glycemic status in a 5-year prospective study of Chinese subjects with impaired glucose tolerance. Metabolism 55:1155-1158
16. Lembo G, De Luca N, Battagli C, Iovino G, Aretini A, Musicco M, Frati G, Pompeo F, Vecchione C, Trimarco B 2001 A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 32:735-740
17. Philip I, Plantefeve G, Vuillaumier-Barrot S, Vicaut E, LeMarie C, Henrion D, Poirier O, Levy BI, Desmonts JM, Durand G, Benessiano J 1999 G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation 99:3096-3098 (Pubitemid 29289072)
18. Perez-Martinez P, Moreno-Conde M, Cruz-Teno C, Ruano J, Fuentes F, Delgado-Lista J, Garcia-Rios A, Marin C, Gomez-Luna MJ, Perez-Jimenez F, Roche HM, Lopez-Miranda J 2010 Dietary fat differentially influences regulatory endothelial function during the postprandial state in patients with metabolic syndrome: from the LIPGENE study. Atherosclerosis 209:533-538
19. Leeson CP, Hingorani AD, Mullen MJ, Jeerooburkhan N, Kattenhorn M, Cole TJ, Muller DP, Lucas A, Humphries SE, Deanfield JE 2002 Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res 90:1153-1158 (Pubitemid 34786899)
20. Ferguson JF, Phillips CM, McMonagle J, Pérez-Martínez P, Shaw DI, Lovegrove JA, Helal O, Defoort C, Gjelstad IM, Drevon CA, Blaak EE, Saris WH, Leszczyń ska-Golabek I, Kiec-Wilk B, Risérus U, Karlström B, Lopez-Miranda J and Roche HM 2010 NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease, and interact with ω-3 polyunsaturated fatty acids. Atherosclerosis 211:539-544
21. Delgado-Lista J, Garcia-Rios A, Perez-Martinez P, Fuentes F, Jiménez- Gomez Y, Gomez-Luna MJ, Parnell LD, Marin C, Lai CQ, Perez- Jimenez F, Ordovas JM, Lopez-Miranda J 2011 Gene variations of nitric oxide synthase regulate the effects of a saturated fat rich meal on endothelial function. Clin Nutr (Edinburgh, Scotland) 30:234-238
22. Fitó M, De la Torre R, Farré-Albaladejo M, Khymenetz O, Marrugat J, Covas MI 2007 Bioavailability and antioxidant effects of olive oil phenolic compounds in humans: a review. Ann Ist Super Sanita 43:375-381
23. Perez-Jimenez F, Alvarez de Cienfuegos G, Badimon L, Barja G, Battino M, Blanco A, Bonanome A, Colomer R, Corella-Piquer D, Covas I, Chamorro-Quiros J, Escrich E, Gaforio JJ, Garcia Luna PP, Hidalgo L, Kafatos A, Kris-Etherton PM, Lairon D, Lamuela- Raventos R, Lopez-Miranda J, Lopez-Segura F, Martinez-Gonzalez MA, Mata P, Mataix J, Ordovas J, Osada J, Pacheco-Reyes R, Perucho M, Pineda-Priego M, Quiles JL, Ramirez-Tortosa MC, Ruiz-Gutierrez V, Sanchez-Rovira P, Solfrizzi V, Soriguer-Escofet F,de la Torre-Fornell R, Trichopoulos A, Villalba-Montoro JM, Villar- Ortiz JR, Visioli F 2005 International conference on the healthy effect of virgin olive oil. Eur J Clin Invest 35:421-424 (Pubitemid 40992770)
24. López-Miranda J, Pérez-Jiménez F, Ros E, De Caterina R, Badimón L, Covas MI, Escrich E, Ordovás JM, Soriguer F, Abiá R, De la Lastra CA, Battino M, Corella D, Chamorro-Quirós J, Delgado-Lista J, Giugliano D, Esposito K, Estruch R, Fernandez-Real JM, Gaforio JJ, La Vecchia C, Lairon D, López-Segura F, Mata P, Menéndez JA, Muriana FJ, Osada J, Panagiotakos DB, Paniagua JA, Pérez-Martinez P, Perona J, Peinado MA, Pineda-Priego M, Poulsen HE, Quiles JL, Ramírez-Tortosa MC, Ruano J, Serra-Majem L, Solá R, Solanas M, Solfrizzi V, De la Torre-Fornell R, Trichopoulou A, Uceda M, Villalba-Montoro JM, Villar-Ortiz JR, Visioli F, Yiannakouris N 2010 Olive oil and health: summary of the II International Conference on Olive Oil and Health Consensus Report, Jaén and Córdoba (Spain) 2008. Nutr Metab Cardiovasc Dis 20:284-294
25. Ruano J, Lopez-Miranda J, Fuentes F, Moreno JA, Bellido C, Perez-Martinez P, Lozano A, Gómez P, Jiménez Y, Pérez Jiménez F 2005 Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J Am Coll Cardiol 46:1864-1868 (Pubitemid 41579809)
26. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith Jr SC, Spertus JA, Costa F 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752 (Pubitemid 41532612)
27. Bucolo G, David H 1973 Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476-482
28. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC 1974 Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475
29. Briggs CJ, Anderson D, Johnson P, Deegan T 1981 Evaluation of the polyethylene glycol precipitation method for the estimation of high-density lipoprotein cholesterol. Ann Clin Biochem 18:177-181 (Pubitemid 11058717)
30. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
31. Riepponen P, Marniemi J, Rautaoja T 1987 Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest 47:739-744 (Pubitemid 18002120)
32. López-Miranda J, Pérez-Martínez P, Marín C, Moreno JA, Gómez P, Pérez-Jiménez F 2006 Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease. Curr Opin Lipidol 17:132-138
33. Cicerale S, Lucas L, Keast R 2010 Biological activities of phenolic compounds present in virgin olive oil. Int J Mol Sci 11:458-479
34. Covas MI, De la Torre K, Farré-Albaladejo M, Kaikkonen J, Fitó M, López-Sabater C, Pujadas-Bastardes MA, Joglar J, Weinbrenner T, Lamuela-Raventós RM, De la Torre R 2006 Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic Biol Med 40:608-616 (Pubitemid 43170812)
35. Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Sanchez- Rovira P, Ramirez-Tortosa MC 2010 Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr Rev 68:191-206
36. Pérez-Jiménez F, Ruano J, Perez-Martinez P, Lopez-Segura F, Lopez- Miranda J 2007 The influence of olive oil on human health: not a question of fat alone. Mol Nutr Food Res 51:1199-1208 (Pubitemid 350013167)
37. Martins MA, Catta-Preta M, Mandarim-de-Lacerda CA, Aguila MB, Brunini TC, Mendes-Ribeiro AC 2010 High fat diets modulate nitric oxide biosynthesis and antioxidant defence in red blood cells from C57BL/6 mice. Arch Biochem Biophys 499:56-61
38. Chang K, Baek SH, Seung KB, Kim PJ, Ihm SH, Chae JS, Kim JH, Hong SJ, Choi KB 2003 The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm. Coron Artery Dis 14:293-299 (Pubitemid 36900657)
39. Ogimoto A, Shigematsu Y, Nakura J, Hara Y, Ohtsuka T, Kohara K, Hamada M, Miki T, Higaki J 2005 Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina. J Mol Med (Berlin, Germany) 83:619-625 (Pubitemid 41176071)
40. Stabler T, Kenjale A, Ham K, Jelesoff N, Allen J 2010 Potential mechanisms for reduced delivery of nitric oxide to peripheral tissues in diabetes mellitus. Ann NY Acad Sci 1203:101-106
41. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J 2000 Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 97:2832-2835 (Pubitemid 30159257)
42. Joshi MS, Mineo C, Shaul PW, Bauer JA 2007 Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J 21:2655-2663 (Pubitemid 47372733)